Reata Pharmaceuticals, Inc. ( NASDAQ:RETA – Get Rating ) CAO Bhaskar Anand sold 2,343 shares of Reata Pharmaceuticals stock in a transaction on Wednesday, June 14th. The shares were sold at an average price of $102.11, for a total value of $239,243.73. Following the completion of the sale, the chief accounting officer now owns 24,898 shares in the company, valued at approximately $2,542,334.78. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website .

https://www.dailypolitical.com/2023/06/16/insider-selling-reata-pharmaceuticals-inc-nasdaqreta-cao-sells-2343-shares-of-stock.html

#dailypolitical